Is MEDVi legit?
Yes, MEDVi is a real, operating telehealth company, and it is not a scam. But its two third-party records disagree, which is worth understanding before you hand over a card. It holds 4.4 out of 5 across 11,000 Trustpilot reviews, while its BBB profile reads F (not accredited), a gap that almost always means billing and cancellation disputes rather than the medicine. On our own methodology it scores 7.7/10, at $179/mo (first month, then $299/mo).
This page is written by GLP-1 Picks, not by MEDVi. We earn commission if you sign up through our link, which never changes the score. Editorial policy.
Who actually operates it
Chicago, IL
What third-party reviewers say
MEDVi (GLP-1 telehealth, real Trustpilot profile at medvi.org) carries a high 4.4/5 TrustScore across ~11,000+ reviews, with praise for fast approval and responsive support, but its BBB profile is an unaccredited F, and recurring complaints across platforms center on billing confusion and slow refunds (ConsumerAffairs sits lower at ~3.6/5).
Reddit sentiment (mixed): No substantial dedicated MEDVi Reddit threads surfaced; aggregated third-party sentiment praises fast approval and responsive support but flags recurring billing and refund-delay complaints.
Trustpilot verified June 19, 2026, external-reviews verification pass..
What people complain about with MEDVi
- •No brand-name Wegovy or Zepbound on the platform (the 2026 expansion added branded Ozempic only)
- •No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms; you can switch to injectable anytime at no extra fee if results lag
Our verdict
MEDVi is the best option for needle-averse users who want a clear pathway from oral to injectable GLP-1 treatment. The micro-dosing options, sleek portal, and 2026 expansion to compounded tirzepatide (both injectable and oral tablet) plus brand-name Ozempic broaden the appeal, with a 4.4/5 Trustpilot rating across roughly 11,000 reviews behind it. If brand-name Wegovy is a must, [Hers](/reviews/hers) offers it at $149/mo via the Novo partnership. For everyone starting oral with the option to step up to injectable, MEDVi is built for exactly that, from $179 for the first month.
MEDVi, $179/mo, scored 7.7/10 on our methodology.
Informational only, not medical advice. Ratings and prices verified at the dates shown and change frequently; confirm on MEDVi's own site before purchasing.